An inactivated vaccine prepared from conidia and mycelial elements of
Trichophyton equinum was developed to control T. equinum infection in
large groups of horses. The vaccine was used in approximately 3,500 he
ad of horses over a 3-year period. Incidence of new infections was red
uced from 40% to essentially 0% over that period. The vaccine protecte
d 87% of vaccinated horses from infection in a controlled exposure stu
dy that caused infection in 52% of non-vaccinated controls. In a prolo
nged pen contact study, 91% of the vaccinates remained free of infecti
on, while 70% of non-vaccinates became infected. When infection did oc
cur in vaccinated individuals, it was limited to a single lesion as co
mpared to more widespread infection in non-vaccinated controls.